These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18006057)

  • 41. Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy.
    Nowak D; Nolte F; Mossner M; Nowak V; Baldus CD; Hopfer O; Noll S; Thiel E; Wagner F; Hofmann WK
    Exp Hematol; 2009 Feb; 37(2):215-224. PubMed ID: 19135900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.
    Abe Y; Muto M; Nieda M; Nakagawa Y; Nicol A; Kaneko T; Goto S; Yokokawa K; Suzuki K
    Exp Hematol; 2009 Aug; 37(8):956-68. PubMed ID: 19409955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
    Schuetz F; Ehlert K; Ge Y; Schneeweiss A; Rom J; Inzkirweli N; Sohn C; Schirrmacher V; Beckhove P
    Cancer Immunol Immunother; 2009 Jun; 58(6):887-900. PubMed ID: 18998129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells.
    Eklöw C; Makrygiannakis D; Bäckdahl L; Padyukov L; Ulfgren AK; Lorentzen JC; Malmström V
    Ann Rheum Dis; 2008 Dec; 67(12):1742-9. PubMed ID: 18250113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro mitogen-stimulated T-cell from hepatitis C virus-positive liver transplantation candidates, increases T-cell activation markers and T-cell proliferation.
    Canivet C; Böhler T; Galvani S; Péron JM; Muscari F; Alric L; Barange K; Salvayre R; Negre-Salvayre A; Durand D; Suc B; Izopet J; Thomsen M; Rostaing L; Kamar N
    Transpl Immunol; 2008 May; 19(2):112-9. PubMed ID: 18503886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
    Gonçalves I; Cherfan P; Söderberg I; Nordin Fredrikson G; Jonasson L
    Autoimmunity; 2009 Mar; 42(3):203-8. PubMed ID: 19301201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders.
    Cortelezzi A; Colombo G; Pellegrini C; Silvestris I; Moronetti Mazzeo L; Bosari S; Lambertenghi Deliliers G; Fracchiolla NS
    Am J Hematol; 2008 Jul; 83(7):531-9. PubMed ID: 18383321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
    Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
    J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
    Zarife MA; Reis EA; Carmo TM; Lopes GB; Brandão EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
    J Med Virol; 2009 Jan; 81(1):49-59. PubMed ID: 19031471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes.
    Pruneri G; Fracchiolla N; Cortelezzi A; Ponzoni M; Maisonneuve P; Lambertenghi-Deliliers G
    Haematologica; 2003 Jan; 88(1):109-10. PubMed ID: 12551833
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes.
    Horny HP; Sotlar K; Valent P
    Leuk Res; 2007 Dec; 31(12):1609-16. PubMed ID: 17604834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Regulatory T cells and Th17 cells populations in myelodysplastic syndromes and its clinical significance].
    Zhu XM; Liu SF; Liu XL; Xiao X; Zhu SC; Zhang GS
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):548-9. PubMed ID: 23827120
    [No Abstract]   [Full Text] [Related]  

  • 55. [Relationship between response to cyclosporine treatment and HLA-DR in MDS].
    Okamoto T
    Rinsho Ketsueki; 2002 Apr; 43(4):265-9. PubMed ID: 12043205
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression of CD34 by megakaryocytes in myelodysplastic syndromes.
    Pellegrini W; Facchetti F; Marocolo D; Pelizzari AM; Capucci A; Rossi G
    Haematologica; 2000 Oct; 85(10):1117-8. PubMed ID: 11025619
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased circulating of myeloid-derived suppressor cells in myelodysplastic syndrome.
    Jiang HJ; Fu R; Wang HQ; Li LJ; Qu W; Liang Y; Wang GJ; Wang XM; Wu YH; Liu H; Song J; Guan J; Xing LM; Ruan EB; Shao ZH
    Chin Med J (Engl); 2013 Jul; 126(13):2582-4. PubMed ID: 23823840
    [No Abstract]   [Full Text] [Related]  

  • 58. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion.
    Wang SA; Yue G; Hutchinson L; Landry ML; Hasserjian RP; Hao S; Galili N; Raza A; Woda BA
    Br J Haematol; 2007 Jul; 138(2):271-5. PubMed ID: 17542981
    [No Abstract]   [Full Text] [Related]  

  • 59. Expression of CD7 in myelodysplastic syndromes (MDS): is this a truly prognostic factor?
    Font P; Subirá D
    Leuk Res; 2008 Jan; 32(1):185-6. PubMed ID: 17383724
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunoregulatory abnormalities in myelodysplastic disorders.
    Baumann MA; Milson TJ; Patrick CW; Libnoch JA; Keller RH
    Am J Hematol; 1986 May; 22(1):17-26. PubMed ID: 3953564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.